These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4843574)

  • 1. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy.
    Metzger AL; Bohan A; Goldberg LS; Bluestone R; Pearson CM
    Ann Intern Med; 1974 Aug; 81(2):182-9. PubMed ID: 4843574
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone.
    Fischer TJ; Rachelefsky GS; Klein RB; Paulus HE; Stiehm ER
    Am J Dis Child; 1979 Apr; 133(4):386-9. PubMed ID: 433855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate therapy in polymyositis.
    Arnett FC; Whelton JC; Zizic TM; Stevens MB
    Ann Rheum Dis; 1973 Nov; 32(6):536-46. PubMed ID: 4760477
    [No Abstract]   [Full Text] [Related]  

  • 4. Dermatomyositis and polymyositis: clinical aspects.
    Kagen LJ
    Clin Exp Rheumatol; 1984; 2(3):271-7. PubMed ID: 6397283
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of corticosteroid-resistant polymyositis with methotrexate.
    Sokoloff MC; Goldberg LS; Pearson CM
    Lancet; 1971 Jan; 1(7688):14-6. PubMed ID: 4099314
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
    Oddis CV; Medsger TA
    J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunosuppressive treatment of steroid-resistant dermatomyositis/polymyositis.
    Wallace DJ; Metzger AL; White KK
    Arthritis Rheum; 1985 May; 28(5):590-2. PubMed ID: 4004968
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disease in polymyositis/dermatomyositis.
    Dickey BF; Myers AR
    Semin Arthritis Rheum; 1984 Aug; 14(1):60-76. PubMed ID: 6385255
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH; Hausner-Sypek DL; Weinblatt ME
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate treatment in dermatomyositis.
    Sarova-Pinhas I; Siegal T; Turgman J; Braham J
    Eur Neurol; 1977; 16(1-6):149-54. PubMed ID: 615706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
    Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Eur Neurol; 2004; 52(1):61-3. PubMed ID: 15240986
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dermatomyositis with methotrexate.
    Malaviya AN; Many A; Schwartz RS
    Lancet; 1968 Aug; 2(7566):485-8. PubMed ID: 4174506
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.
    Bohan A; Peter JB; Bowman RL; Pearson CM
    Medicine (Baltimore); 1977 Jul; 56(4):255-86. PubMed ID: 327194
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
    Kasteler JS; Callen JP
    J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in adult polymyositis.
    Riddoch D; Morgan-Hughes JA
    J Neurol Sci; 1975 Sep; 26(1):71-80. PubMed ID: 169327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dermatomyositis with methotrexate and prednisone.
    Giannini M; Callen JP
    Arch Dermatol; 1979 Oct; 115(10):1251-2. PubMed ID: 507874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.